Recent DCPH Stock Price | DCPH Stock Predictions | |
$14.62 | +77.09% |
$25.89 |
Recent DCPH Analyst Ratings Breakdown, Making DCPH Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 8 | 7 | 7 | 8 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 1 | 1 | 1 | 1 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 1 | 1 | 1 | 1 |
Average rating: | 1.6 | 1.67 | 1.67 | 1.6 |
For the DCPH stock predictions from the analysts covering Deciphera Pharmaceuticals Inc, we have collected all of the individual DCPH stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 9 different analysts covering DCPH (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since DCPH stock predictions may vary widely, another useful metric to consider is the median DCPH stock prediction, which represents the price at which half of the analysts
made DCPH stock predictions that were higher and half made DCPH stock predictions that were lower. This makes for a different take on the DCPH stock predictions out there, as compared to average or mean.
And that median across all the individual DCPH stock predictions was: $26.0 as of 2024-04-25.
The very highest of the DCPH stock predictions for one year price target was $34.0, while the very lowest of the DCPH stock predictions in the analyst group was
$16.0 (with a standard deviation of $5.325). Get the latest Zacks research report on DCPH — FREE
Find out: DCPH next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
BCRX Stock Predictions
IMXI Stock Predictions
TPTX Stock Predictions
MMC Stock Predictions
ALIM Stock Predictions
CYRX Stock Predictions
MDC Stock Predictions
SRAX Stock Predictions
TRI Stock Predictions
|
|
Buy (3.40 out of 4) 55th percentile
(ranked higher than approx. 55% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |